Stratos Wealth Partners LTD. acquired a new stake in Myomo, Inc. (NYSEAMERICAN:MYO – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 25,000 shares of the company’s stock, valued at approximately $125,000. Stratos Wealth Partners LTD. owned about 0.09% of Myomo at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. AIGH Capital Management LLC grew its stake in Myomo by 9.4% in the third quarter. AIGH Capital Management LLC now owns 2,188,883 shares of the company’s stock valued at $2,430,000 after acquiring an additional 188,883 shares during the period. Worth Venture Partners LLC grew its stake in Myomo by 24.9% in the third quarter. Worth Venture Partners LLC now owns 1,397,861 shares of the company’s stock valued at $1,552,000 after acquiring an additional 278,544 shares during the period. UBS Group AG acquired a new position in Myomo in the third quarter valued at about $555,000. Essex Investment Management Co. LLC acquired a new position in Myomo in the third quarter valued at about $325,000. Finally, Vanguard Group Inc. acquired a new position in Myomo in the third quarter valued at about $177,000. Institutional investors own 44.99% of the company’s stock.
Insider Transactions at Myomo
In other news, Director Thomas F. Kirk acquired 50,000 shares of Myomo stock in a transaction dated Thursday, March 14th. The stock was bought at an average cost of $3.50 per share, with a total value of $175,000.00. Following the completion of the transaction, the director now directly owns 186,499 shares of the company’s stock, valued at $652,746.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 3.20% of the stock is owned by insiders.
Myomo Stock Down 1.4 %
Myomo (NYSEAMERICAN:MYO – Get Free Report) last posted its quarterly earnings data on Thursday, March 7th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The firm had revenue of $4.76 million for the quarter, compared to analyst estimates of $4.70 million. Myomo had a negative return on equity of 84.72% and a negative net margin of 42.34%. As a group, equities research analysts anticipate that Myomo, Inc. will post -0.18 earnings per share for the current year.
About Myomo
Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Further Reading
- Five stocks we like better than Myomo
- Buy P&G Now, Before It Sets A New All-Time High
- United Airlines Soars on Earnings Beat
- Manufacturing Stocks Investing
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Want to see what other hedge funds are holding MYO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Myomo, Inc. (NYSEAMERICAN:MYO – Free Report).
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.